EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax

Abstract Background Acute myeloid leukemia (AML) is an aggressive hematological cancer resulting from uncontrolled proliferation of differentiation-blocked myeloid cells. Seventy percent of AML patients are currently not cured with available treatments, highlighting the need of novel therapeutic str...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Katie Fooks, Gabriela Galicia-Vazquez, Victor Gife, Alejandro Schcolnik-Cabrera, Zaynab Nouhi, William W. L. Poon, Vincent Luo, Ryan N. Rys, Raquel Aloyz, Alexandre Orthwein, Nathalie A. Johnson, Laura Hulea, Francois E. Mercier
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-12-01
coleção:	Journal of Experimental & Clinical Cancer Research
Assuntos:	AML eIF4A BCL2 MCL1 BCL-XL mTORC1
Acesso em linha:	https://doi.org/10.1186/s13046-022-02542-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!